Crossmark Global Holdings
BNTX icon

Crossmark Global Holdings’s BioNTech BNTX Stock Holding History

Crossmark Global Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.06M Sell
20,927
-7
-0% -$680 0.03% 433
2026
Q2 		$1.95M Buy
20,934
+12,285
+142% +$1.16M 0.03% 462
2026
Q1 		$769K Buy
+8,649
New +$889K 0.01% 696

Other funds holding BNTX

Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LBP AM
LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Crossmark Global Holdings's BNTX Position: Q3 2026 in Review

Crossmark Global Holdings reduced its BioNTech (BNTX) stake by 0.03% in Q3 2026, selling an estimated $680 and leaving 20,927 shares worth $2.06M. The position accounts for 0.03% of the portfolio, ranked #433.

Crossmark Global Holdings first reported a position in BNTX in Q1 2026 and has held it in 3 quarters since. 120 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Crossmark Global Holdings held 20,927 shares of BioNTech worth $2.06M as of Q3 2026.
  • Crossmark Global Holdings sold 7 BioNTech shares in Q3 2026, an estimated $680.
  • BioNTech made up 0.03% of Crossmark Global Holdings's portfolio in Q3 2026, its #433 holding.
  • Crossmark Global Holdings first reported a position in BioNTech in Q1 2026 and has held it in 3 quarters since.
  • 120 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.